首页> 外文OA文献 >Futibatinib, an investigational agent for the treatment of intrahepatic cholangiocarcinoma: evidence to date and future perspectives

【2h】

Futibatinib, an investigational agent for the treatment of intrahepatic cholangiocarcinoma: evidence to date and future perspectives

机译：Futibatinib，一种治疗肝内胆管癌的调查剂：迄今为止和未来观点的证据

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Alessandro Rizzo; Angela Dalia Ricci; Giovanni Brandi;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. IDH1 Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment—Current State and Future Perspectives [J] . Fabiana Crispo, Michele Pietrafesa, Valentina Condelli, Molecules . 2020,第16期

机译：IDH1靶向肝内胆管癌治疗 - 当前状态和未来观点的新潜在选择
2. Intrahepatic cholangiocarcinoma: Limitations for resectability, current surgical concepts and future perspectives [J] . European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology . 2020,第5期

机译：肝内胆管癌：可塞可神分，目前的手术概念和未来观点的限制
3. Intrahepatic cholangiocarcinoma - current perspectives and treatment algorithm [J] . Lurje G., Bednarsch J., Roderburg C., Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen . 2018,第11期

机译：肝内胆管癌 - 当前的观点和治疗算法
4. Improving the Accuracy of Intrahepatic Cholangiocarcinoma Subtype Classification by Hidden Class Detection via Label Smoothing [C] . Jing Wei Tan, Kanggeun Lee, Kyoungbun Lee, IEEE International Symposium on Biomedical Imaging . 2021

机译：通过标签平滑通过隐藏类检测提高隐式胆管癌亚型分类的准确性
5. Burden of Future Liver Disease in Patients with Intrahepatic Cholestasis of Pregnancy [D] . Monrose, Erica. 2020

机译：怀孕肝内胆汁淤积患者未来肝病的负担
6. IDH1 Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment—Current State and Future Perspectives [O] . Fabiana Crispo, Michele Pietrafesa, Valentina Condelli, 2020

机译：IDH1靶向肝内胆管癌治疗 - 当前状态和未来观点的新潜在选择
7. Immune Checkpoint Inhibitors and Novel Agents in the Treatment of Metastatic Urothelial Cancer—Current Status and Future Perspectives [O] . Petros Grivas 2019

机译：免疫检查点抑制剂和新药治疗转移性尿路上皮癌症 - 现状和未来观点

Futibatinib, an investigational agent for the treatment of intrahepatic cholangiocarcinoma: evidence to date and future perspectives

著录项

引文网络

相似文献

相关主题

期刊订阅